Mark C. Schneyer - Mar 24, 2025 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
EVP, CHIEF FINANCIAL OFFICER
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
Stock symbol
ACAD
Transactions as of
Mar 24, 2025
Transactions value $
-$54,066
Form type
4
Date filed
3/26/2025, 08:06 PM
Previous filing
Feb 25, 2025
Next filing
Apr 8, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACAD Common Stock Options Exercise +6.18K +11.47% 60.1K Mar 25, 2025 Direct F1
transaction ACAD Common Stock Sale -$54.1K -3.17K -5.28% $17.05 56.9K Mar 26, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACAD Stock Option (Right to Buy) Award $0 +111K $0.00 111K Mar 24, 2025 Common Stock 111K $17.23 Direct F3
transaction ACAD Restricted Stock Units Award $0 +32.6K $0.00 32.6K Mar 24, 2025 Common Stock 32.6K Direct F1, F4
transaction ACAD Restricted Stock Units Options Exercise $0 -6.18K -25% $0.00 18.5K Mar 25, 2025 Common Stock 6.18K Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).
F3 25% of the shares subject to the Stock Option will vest and become exercisable on March 24, 2026. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.
F4 The restricted stock units vest in four equal annual installments beginning March 24, 2026.
F5 The restricted stock units vest in four equal annual installments beginning March 25, 2025.